跳到正文
原文
The Lancet· Sara Domínguez-Rodríguez, Alfredo Tagarro, Cinta Moraleda, W Chris Buck, Hilda Mujuru, Chishala Chabala, Tisungane Mvalo, Pui-Ying Iroh-Tam, Anélsio Cossa, Lola Madrid, Jahit Sacarlal, Alfeu Passanduca, Uneisse Cassia, Stella Langa, Hellen Tukamuhebwa Aanyu, Abner Tagoola, Constantine Mutata, Bwendo Nduna, Elizabeth Nkosi, Lughano Ghambi, Matthew Bates, Sheila Fernández-Luis, Kajal Chhaganlal, Sara Machava, Damalie Nalwanga, Denis Nansera, Mutsa Bwakura-Dangarembizi, Natasha Namuziya, Franklyn Nkongho Egbe, John Tembo, Álvaro Ballesteros, Raoul Moh, Lilit Manukyan, David Lora, Olivier Marcy, Tom G Jacobs, David Burger, Quique Bassat, Valeriane Leroy, Alessandra Nardone, Victor Musiime, Pablo Rojo, Empirical Clinical Trial Group·· 5 天前精选AI 评分58

EMPIRICAL试验:经验性抗结核治疗未降低HIV感染婴儿重症肺炎死亡率

[Articles] Empirical tuberculosis treatment in infants living with HIV hospitalised with severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label, 2 × 2 factorial, controlled superiority trial

AI 导读

非洲多中心随机对照试验EMPIRICAL显示,在因重症肺炎住院的HIV感染婴儿中,经验性抗结核治疗(eTB-T)在降低全因死亡率方面未优于临床和微生物学指导策略。研究同时指出,非eTB-T组中随访期间最终启动抗结核治疗的婴儿比例较高,可能缩小了两种策略之间的差异并削弱了检测结局差异的能力。

推荐理由

EMPIRICAL试验显示经验性抗结核治疗未降低HIV感染婴儿重症肺炎的全因死亡率,为临床决策提供随机对照证据。

来源:The Lancet · thelancet.com